March 24, 2006
Article
From mastectomy to reconstruction and beyond.
FDA Approves Biosimilars for Cancer-Related Skeletal Events
Imfinzi Plus Chemo May Improve Event-Free Survival in Gastric, GEJ Cancers
177Lu-edotreotide May Delay Progression in Neuroendocrine Tumor Subset
The Dawn of a New Era in Cancer Treatment